• Conference Proceeding

United States Policy Implications of Generic Substitution of Branded Human Immunodeficiency Virus Medications

Citation

Hogue, S., Brogan, A., & Goodwin, B. (2013). United States Policy Implications of Generic Substitution of Branded Human Immunodeficiency Virus Medications. In [16], pp. A364–A365. .

Abstract